FORT
MYERS, Fla., May 1, 2024
/PRNewswire/ -- In a case study released today by Florida
Cancer Specialists & Research Institute, LLC, community
oncology practices emerge as the preferred site of service for
cancer treatment, challenging the traditional dominance of
hospitals and academic centers. The summarized findings within this
case study shed light on the significant advantages offered by
community oncology practices in delivering high-quality care to
cancer patients.
"The collective insights we reveal in this case study are poised
to spark meaningful discussions among policymakers, health care
stakeholders, and the general public about the future of cancer
care delivery," says FCS Chief Executive Officer Nathan H. Walcker. "By amplifying the voice of
community oncology practices, the study advocates for a more
inclusive, patient-centric healthcare system that celebrates
diversity and innovation.
The study, titled " Evaluating the Site of Service and Oncology
Care Costs," delves into key factors influencing patient outcomes,
cost-effectiveness, and overall satisfaction with care delivery
models. Contrary to common perceptions, the findings reveal that
community oncology practices outperform hospitals and academic
centers in several critical areas: personalized care, convenience
and accessibility, cost-effectiveness and a collaborative
approach.
Community oncology practices excel in providing personalized
treatment plans tailored to individual patient needs. With a
patient-centric approach, these practices prioritize empathy,
communication, and accessibility, fostering strong patient-provider
relationships crucial for navigating the complexities of cancer
care.
Patients receiving care in a community oncology setting, often
located close to their homes, experience reduced travel times and
related expenses and find it easier to access care. Patient
proximity to care is a large contributor to improved patient
adherence to treatment regimens, which directly impacts patient
outcomes.
The study also underscores the cost-effectiveness of care
delivery in community oncology settings. By avoiding the overhead
expenses associated with large hospital systems and through close
relationships with insurers, community practices offer competitive
pricing without compromising the quality of care, thereby
alleviating financial burdens on patients and payers alike.
Contrary to misconceptions, community oncology practices foster
collaboration with academic institutions and hospitals, leveraging
shared expertise and resources to optimize patient outcomes. This
collaborative spirit promotes innovation, knowledge exchange, and
continuous improvement in cancer care delivery.
Recognizing the fundamental role played by community oncology
practices in the healthcare landscape, FCS President &
Managing Physician Lucio N. Gordan,
MD says, "The findings summarized in this case study challenge the
conventional wisdom surrounding cancer care delivery. Community
oncology practices represent a cornerstone of comprehensive cancer
care, offering a holistic approach that prioritizes patient
well-being and clinical excellence."
Read the case study here.
About Florida Cancer Specialists & Research Institute,
LLC: (FLCancer.com)
Florida Cancer Specialists & Research Institute (FCS) offers
patients access to more clinical trials than any private oncology
practice in Florida. The majority
of new cancer drugs recently approved for use in the U.S. were
studied in clinical trials with FCS participation.* Recognized for
our research, FCS is a recipient of the national Clinical Trials
Participation Award presented by the American Society of Clinical
Oncology (ASCO). FCS physicians, trained in prestigious medical
schools and research institutes, are consistently ranked nationally
as Top Doctors by U.S. News & World Report.
Celebrating its 40th year in 2024, FCS has built a
national reputation for excellence that is reflected in exceptional
and compassionate patient care, driven by innovative clinical
research, cutting-edge technologies and advanced treatments,
including targeted therapies genomic-based treatment and
immunotherapy. Our highest values are embodied by our outstanding
team of highly trained and dedicated physicians, clinicians and
staff.
*Prior to approval
View original content to download
multimedia:https://www.prnewswire.com/news-releases/new-case-study-highlights-community-oncology-practices-as-preferred-site-of-service-over-hospitals-and-academic-centers-302133211.html
SOURCE Florida Cancer Specialists & Research Institute